NSEPress ReleaseResults23 Oct 2026
SBI Funds Management Limited
Press Release
SBI Funds Management Limited has announced its financial results for the quarter and half year ended September 30, 2026, with a total mutual fund assets under management (AUM) of ₹13,140 billion, a 6% year-over-year increase.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults23 Oct 2026
GE Vernova T&D India Limited
Analysts/Institutional Investor Meet/Con. Call Updates
GE Vernova T&D India Limited has informed the Exchange about the schedule of an Earnings Conference call with Analysts / Institutional Investors to discuss the Company's financial results for the quarter ended September 30, 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults23 Oct 2026
Arkade Developers Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Arkade Developers Limited has informed the Exchange about Schedule of meet for an earnings conference call with analysts and investors to update the performance of the Company for the quarter and half year ended September 30, 2026.
NSEInvestor PresentationResults23 Oct 2026
SBI Funds Management Limited
Investor Presentation
SBI Funds Management Limited has released its investor presentation for Q2 FY27, highlighting its financial results and industry overview.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults23 Oct 2026
Dr. Agarwal's Health Care Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Dr. Agarwal's Health Care Limited has informed the Exchange about the schedule of a meeting of the Board of Directors to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2026, and will host an Earnings / Analyst Conference on November 05, 2026.
NSEStatement of deviation(s) or variation(s) under Reg. 32Results23 Oct 2026
Bank of India
Statement of deviation(s) or variation(s) under Reg. 32
Bank of India has submitted a statement indicating deviation or variation in the use of proceeds of public issue, rights issue, preferential issue, and issue of listed Non-Convertible Debt Securities for the quarter ended September 30, 2026, with no deviation or variation reported.
NSEAgreementsResults23 Oct 2026
Jupiter Life Line Hospitals Limited
Agreements
Jupiter Life Line Hospitals Limited has informed the Exchange about Agreements, including the approval of unaudited financial results for the quarter and half year ended on September 30, 2026, the incorporation of a wholly owned subsidiary, and the acquisition of land for ₹150 Crores.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults23 Oct 2026
Fairchem Organics Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Fairchem Organics Limited has submitted a link for the audio recording of its earnings call held on October 23, 2026, to discuss unaudited financial results for the quarter and six months ended September 30, 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults23 Oct 2026
Metro Brands Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Metro Brands Limited has informed the Exchange about the transcript of the earnings conference call for the quarter and half year ended September 30, 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults23 Oct 2026
Intellect Design Arena Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Intellect Design Arena Limited has informed the Exchange about the schedule of its Earning Conference Call for Q2' 27, to be held on October 30, 2026, at 5:00 P.M IST.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults23 Oct 2026
Oberoi Realty Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Oberoi Realty Limited has informed the Exchange about the transcript of the conference call on Q2FY27 results and business updates, which is available on the company's website.
NSEInvestor Presentation▲ PositiveResults23 Oct 2026
Dr. Reddy's Laboratories Limited
Investor Presentation
Dr. Reddy's Laboratories Limited has announced its Q2 FY27 unaudited financial results, showing consistent double-digit base business growth, with EBITDA margin at 20.6% and net cash surplus at ₹2,502 Cr.
NSEOutcome of Board MeetingResults23 Oct 2026
SBI Funds Management Limited
Outcome of Board Meeting
SBI Funds Management Limited has submitted its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, and has also approved the appointment of Mr. Giridhar Sanjeevi as the Independent Director of the Company. The Board has also considered and approved the reclassification of Indian Digital Payment Intelligence Corporation and AIXIGO TR YAZILIM LIMITED SIRKETI from the 'Promoter Group' category to 'Public' category.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults23 Oct 2026
Monte Carlo Fashions Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Monte Carlo Fashions Limited has informed the Exchange about the schedule of a post-results conference call for Q2 FY27, to be held on November 4, 2026.
NSECopy of Newspaper PublicationResults23 Oct 2026
Cybertech Systems And Software Limited
Copy of Newspaper Publication
Cybertech Systems And Software Limited has informed the Exchange about Copy of Newspaper Publication related to Un-audited Financial Results (Consolidated and Standalone) for the quarter and half year ended September 30, 2026.
NSEInvestor PresentationResults23 Oct 2026
Repro India Limited
Investor Presentation
Repro India Limited has informed the Exchange about Investor Presentation, which includes Q2 FY27 performance highlights, digital business growth, and consolidated revenue expansion.
NSEUpdates▲ PositiveResults23 Oct 2026
Cybertech Systems And Software Limited
Updates
Cybertech Systems And Software Limited has announced its unaudited financial results for the quarter ended September 30, 2026, with revenue of ₹ 780.3 million, up 16.9% YoY, and profit after tax of ₹ 86.8 million.
NSEOutcome of Board MeetingResults23 Oct 2026
Dr. Reddy's Laboratories Limited
Outcome of Board Meeting
Dr. Reddy's Laboratories Limited has submitted its unaudited financial results for the quarter and half-year ended September 30, 2026, to the National Stock Exchange of India Ltd.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults23 Oct 2026
Privi Speciality Chemicals Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Privi Speciality Chemicals Limited has scheduled an Earnings Conference Call on October 30, 2026, to discuss its operational and financial performance for the quarter and half year ended September 30, 2026.
NSEPress Release▲ PositiveResults23 Oct 2026
Crisil Limited
Press Release
Crisil Limited has announced its unaudited financial results for the third quarter ended September 30, 2026, with income from operations up 20.2% and profit before tax up 5.3%.